Follicular dendritic cells and B cell tolerance
滤泡树突状细胞和 B 细胞耐受
基本信息
- 批准号:8431334
- 负责人:
- 金额:$ 24.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-03-01 至 2014-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressAntibodiesAntigen-Antibody ComplexAntigensAutoantigensAutoimmune DiseasesB cell differentiationB-Cell DevelopmentB-LymphocytesBindingBone MarrowCD32 AntigensCell MaturationCellsComplement 3d ReceptorsComplement ReceptorDataDefectDevelopmentDucksEventFailureFollicular Dendritic CellsGene ExpressionGene ProteinsGenesGeneticHematopoieticImmigrantImmuneLongevityLymphoid TissueMature B-LymphocyteMembraneMicroRNAsModelingMuramidaseMusOutcomePeripheralPredispositionProcessReactionRoleSignal TransductionSpleenStagingStimulusStructure of germinal center of lymph nodeSystemSystemic Lupus ErythematosusT-LymphocyteTimeValidationWorkautoreactive B cellbasedesign and constructionegginsightmouse modelnovelperipheral toleranceprogenitorprotein functionresearch study
项目摘要
DESCRIPTION (provided by applicant): Follicular dendritic cells (FDCs) are recognized as critical stromal components of the secondary lymphoid tissues that retain antigen and immune complexes, but also respond to environmental stimuli and provide soluble factors, including BAFF, that impact late B cell differentiation. We hypothesize that FDCs may also be important for the retention of self-antigens such that the transient or episodic presence of a self-antigen can be captured. We propose that retention of autoantigens by FDCs may provide an important function in the continual elimination of autoreactive B cells as they complete late maturation in the spleen as "transitional" B cells. Selection events at this stage of development are not well understood and contrast with those described for early B cell maturation in the bone marrow. In this proposal, we introduce a new mouse model of B cell tolerance based upon the conditional expression of a membrane-bound self-antigen on FDCs. We provide the first direct evidence for FDCs as having a role in peripheral B cell tolerance. In the proposed work, we will: (i) Characterize the late B cell development block imposed by FDC-bound self-antigen. (ii) Use forced expression of microRNAs that are differential expressed in transitional and mature B cells to identify genes that are important for tolerance susceptibility of T1 cells.
描述(由申请人提供):滤泡树突细胞 (FDC) 被认为是次级淋巴组织的关键基质成分,其保留抗原和免疫复合物,但也对环境刺激做出反应并提供可溶性因子,包括影响晚期 B 细胞分化的 BAFF。我们假设 FDC 对于保留自身抗原也可能很重要,这样可以捕获短暂或偶发的自身抗原的存在。我们认为,FDC 保留自身抗原可能在持续消除自身反应性 B 细胞中发挥重要作用,因为它们作为“过渡”B 细胞在脾脏中完成晚期成熟。这一发育阶段的选择事件尚未得到充分理解,并且与骨髓中早期 B 细胞成熟的选择事件形成鲜明对比。在本提案中,我们引入了一种新的 B 细胞耐受小鼠模型,该模型基于 FDC 上膜结合自身抗原的条件表达。我们首次提供了 FDC 在外周 B 细胞耐受中发挥作用的直接证据。在拟议的工作中,我们将: (i) 表征由 FDC 结合的自身抗原造成的晚期 B 细胞发育障碍。 (ii) 使用在过渡 B 细胞和成熟 B 细胞中差异表达的 microRNA 的强制表达来识别对 T1 细胞耐受敏感性重要的基因。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT C RICKERT其他文献
ROBERT C RICKERT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT C RICKERT', 18)}}的其他基金
Characterization of a non-canonical role for Foxo1 in B cell lymphoma
Foxo1 在 B 细胞淋巴瘤中的非典型作用的表征
- 批准号:
8920519 - 财政年份:2014
- 资助金额:
$ 24.38万 - 项目类别:
Characterization of a non-canonical role for Foxo1 in B cell lymphoma
Foxo1 在 B 细胞淋巴瘤中的非典型作用的表征
- 批准号:
8692377 - 财政年份:2014
- 资助金额:
$ 24.38万 - 项目类别:
Characterization of Twixt: a novel membrane adaptor protein in B cells
Twixt 的表征:B 细胞中的一种新型膜接头蛋白
- 批准号:
8369296 - 财政年份:2012
- 资助金额:
$ 24.38万 - 项目类别:
Functional Antagonists of EBI12/GPR183 as chemical probes for inflammation
EBI12/GPR183 的功能拮抗剂作为炎症化学探针
- 批准号:
8441575 - 财政年份:2012
- 资助金额:
$ 24.38万 - 项目类别:
Characterization of Twixt: a novel membrane adaptor protein in B cells
Twixt 的表征:B 细胞中的一种新型膜接头蛋白
- 批准号:
8496712 - 财政年份:2012
- 资助金额:
$ 24.38万 - 项目类别:
Follicular dendritic cells and B cell tolerance
滤泡树突状细胞和 B 细胞耐受
- 批准号:
8321386 - 财政年份:2012
- 资助金额:
$ 24.38万 - 项目类别:
Functional Antagonists of EBI12/GPR183 as chemical probes for inflammation
EBI12/GPR183 的功能拮抗剂作为炎症化学探针
- 批准号:
8328179 - 财政年份:2012
- 资助金额:
$ 24.38万 - 项目类别:
Elucidating IKK1 function in germinal center B cell differentiation
阐明 IKK1 在生发中心 B 细胞分化中的功能
- 批准号:
8053310 - 财政年份:2010
- 资助金额:
$ 24.38万 - 项目类别:
Elucidating IKK1 function in germinal center B cell differentiation
阐明 IKK1 在生发中心 B 细胞分化中的功能
- 批准号:
7918323 - 财政年份:2010
- 资助金额:
$ 24.38万 - 项目类别:
Functional distinctions of IgM vs. IgG-containing B cell receptors
IgM 与包含 IgG 的 B 细胞受体的功能差异
- 批准号:
8077304 - 财政年份:2010
- 资助金额:
$ 24.38万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 24.38万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 24.38万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 24.38万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 24.38万 - 项目类别:
Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 24.38万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 24.38万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 24.38万 - 项目类别:
Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 24.38万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 24.38万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 24.38万 - 项目类别:














{{item.name}}会员




